Hemp Licence vs Cannabis Licence in India: What Does Your Business Need?

A practical guide for Indian product founders and overseas companies exploring the Indian market.

A founder wants to launch an Ayurvedic cannabis brand. An overseas company wants to supply CBD ingredients. Another business wants to buy Indian cannabis flower for export.

Each asks a similar question: “Do we need a hemp licence or a cannabis licence?”

The useful answer starts with the proposed business. What material will you handle?

Where will it come from? What will you make, and who will buy it?

The distinction is about the scope of the permission: the material, activity, purpose and location it covers. Treating “hemp licence” and “cannabis licence” as two interchangeable business permits can lead to expensive mistakes.

What is the difference between a hemp licence and a cannabis licence?

In business discussions, “hemp licence” often refers to permission associated with industrial cultivation. “Cannabis licence” is a broader expression that needs clarification: it could refer to cultivation, processing, manufacturing or research under a particular framework.

The NDPS Act itself uses the term “cannabis (hemp)” for specified controlled forms, including charas and ganja. Its definition of ganja excludes seeds and leaves when they are not accompanied by the flowering or fruiting tops. Section 14 provides for conditional permission to cultivate for fibre, seed or horticultural purposes. These provisions do not create one national licence covering every cannabis business. NDPS Act, sections 2 and 14

Use the following questions to clarify what a supplier, consultant or prospective partner means:

When someone says…	Ask them to establish…
“We have a hemp licence.”	Which authority issued it, for which premises, material and activities?
“We manufacture cannabis products.”	Which formulations and manufacturing activities are covered by their approvals?
“Our cannabis is cultivated.”	Which cultivation records connect the source to the batch being offered?
“We can export.”	Which product, destination and legal route have been assessed?
“Our CBD is legal abroad.”	How the exact ingredient or finished product would be classified in India.

A licence copy is the beginning of that review. Read its conditions and match them to the transaction you intend to undertake.

For an Ayurvedic brand, start with the formulation

Before choosing a factory or commissioning packaging, define the product: its ingredients, plant parts, extract specifications, dosage form, intended use and proposed claims.

Ayurvedic medicines have a specific framework under the Drugs and Cosmetics Act and Rules. A product does not enter that framework simply because it contains a botanical ingredient or carries an “Ayurvedic” label.

Classical and patent or proprietary formulations require the appropriate assessment. Bhanga, except seeds, is listed in Schedule E(1), which also makes the relevant precautions important. Drugs and Cosmetics Act and Rules: section 3, Chapter IVA and Schedule E(1)

For a founder evaluating a manufacturing partner, we suggest five practical questions:

1. What is the regulatory basis for this specific formulation?

2. Do the manufacturer's licence and product permissions cover the proposed work?

3. How will the cannabis-derived material be sourced and documented?

4. Who will control specifications, testing, batch release and complaints?

5. What restrictions must be reflected in the label, claims and sales process?

Clarify who will hold each responsibility: your company, the manufacturer, the ingredient supplier or another authorised party. Put this allocation into the operating plan and commercial agreement.

For example, a founder proposing an oral oil for a specific therapeutic use should settle the formulation and regulatory basis before selecting a bottle or copying the claims of an overseas CBD brand.

Is the raw material from cultivated cannabis?

This is one of the questions we receive at Delta. It cannot be answered for the whole market with a single yes or no.

Ask for evidence about the actual supply offered to your business. A supplier's description of material as “cultivated,” “Himalayan” or “hemp-derived” is insufficient to establish its origin or suitability.

Our recommended sourcing review covers:

• The identified source and the basis on which material was obtained.

• The precise plant part supplied and any processing already performed.

• The permissions relevant to the supplier's role.

• Batch records, invoices and applicable movement documents.

• A certificate of analysis linked to the supplied batch.

• Specifications for cannabinoid content and relevant contaminants.

• 
  

If a supplier claims licensed cultivation, request the cultivation licence and records connecting the harvest to the batch. If the material has another origin, establish the relevant collection or procurement basis instead.

A laboratory report describes the tested sample. It does not, by itself, establish the lawful origin of a commercial consignment.

For a product brand, this review also serves a commercial purpose. Before committing to a launch, find out whether the supplier can deliver repeat batches against the specification your formulation needs.

Himachal Pradesh and Uttarakhand: what should a founder compare?

Avoid selecting a state simply because it appears in a hemp-industry headline. Compare the proposed activity and supply chain against the applicable state documents.

Himachal Pradesh's documents dated 16 July and 22 July 2026 distinguish medical/scientific and industrial frameworks.

The medical document identifies cultivation and manufacturing through Forms CC-2 and CC-M. The industrial document uses CH-2 and CH-M. Their definitions of licensed cultivators refer to supplying licensed manufacturers within the state. Both documents repeatedly exclude charas and ganja from relevant descriptions of covered material.

That wording deserves particular attention from anyone proposing flower supply or a supply chain that crosses state boundaries. It should not be paraphrased into a promise that every cannabis activity is available.

Uttarakhand's Excise Department has a dedicated industrial Hemp Section. A product business considering a partner there should obtain the relevant current order and the partner's actual permissions before comparing its proposal with Himachal's framework. Uttarakhand Excise Department: Hemp Section

Decision	Himachal Pradesh	Uttarakhand
Which framework needs examination?	Distinguish the July 2026 medical/scientific document from the industrial order.	Obtain the current order and licence conditions relevant to the proposed hemp activity.
What should a buyer establish?	How the proposed material and recipient fit the stated scope, including the in-state manufacturer wording.	What the supplier may produce, possess and supply under its actual permissions.
What should an Ayurvedic brand establish?	How the proposed sourcing arrangement connects to the manufacturer's drug permissions.	How the proposed sourcing arrangement connects to the manufacturer's drug permissions.
What should an overseas company investigate separately?	The legal route for the exact international transaction.	The legal route for the exact international transaction.

This is a comparison of decisions to investigate, not a ranking of which state is easier or cheaper. A sound commercial comparison needs the same proposed product, scale and operating model in both states.

Can I export cannabis flowers from India?

A state cultivation licence is not sufficient evidence that you can export flower.

International trade in controlled material sits within the central framework. State permissions and international permissions answer different questions. The Narcotics Control Bureau explains that the NDPS Act divides regulatory powers between the Centre and the states. NCB: Policy, Strategy and Mechanism

For Himachal specifically, the exclusions described above are a reason to examine the proposed material before discussing export volumes or prices.

If flower exports are central to your business plan, commission a transaction-specific review at the start. It should establish whether a lawful route exists under the current central rules and export policy, what the Indian supplier can supply, and what the destination permits the buyer to receive. Medical use in the destination is not enough to settle the Indian side.

Until that review is complete, keep proposed export revenue out of the committed base case of your financial model. A prospective buyer's interest is useful commercial evidence, but it does not resolve the regulatory question.

Can an overseas company ship its products to India?

Do not assume that an overseas authorisation transfers to India. Begin with a review of the exact product and proposed recipient.

Prepare a product dossier containing the full composition, botanical source and plant part, manufacturing process, cannabinoid analysis, dosage form, intended use, label and claims. Identify whether the shipment would contain an ingredient, research material or finished product.

For medicines, the Drugs and Cosmetics framework contains import provisions as well as manufacturing provisions. Those must be considered alongside any applicable narcotics and trade controls. Drugs and Cosmetics Act: Chapter III

The commercial assessment should then compare the realistic options for that product: direct import where legally available, a suitably authorised Indian manufacturing arrangement, or a change to the proposed product. None should be assumed feasible before classification and permission checks.

This is why “Can we send you our CBD oil?” needs more information than a catalogue and a price list. A bulk ingredient and a retail bottle may require different assessments, even when they originate from the same extract.

What should you establish before investing?

Write a one-page project brief that answers six questions:

1. What exactly will the business sell?

2. What plant material or ingredient will it use?

3. Where will sourcing, processing and manufacturing occur?

4. Which party will perform each activity?

5. Who is the intended customer, and in which country?

6. Which permissions have been verified, and which remain assumptions?

   
   

Use that brief before signing a supply agreement, paying a manufacturing deposit or setting a launch date. It makes regulatory advice more specific and helps identify whether the main unresolved issue is the formulation, source, partner or route to market.

Discuss your proposed project with Delta

Delta Botanicals & Research supports businesses exploring Ayurvedic cannabis products and entry into India's regulated cannabis and hemp sector.

Submit your project details to info@deltabotanicals.in with the subject “India cannabis project assessment.”

Include your company and country, proposed product, available specifications, sourcing or manufacturing plan, target market, indicative budget and timeline. This helps us understand the enquiry and identify the appropriate next step.

For a focused discussion of your proposed business, request a 60-minute advisory session at ₹15,000 + GST through the same email address.

This article provides general business information. A specific transaction requires assessment against the applicable current rules and permissions.